{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Axial+Spondylarthritis+%28axSpA%29", "query": { "condition": "Axial Spondylarthritis (axSpA)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 103, "total_pages": 11, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Axial+Spondylarthritis+%28axSpA%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T04:15:13.638Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07148414", "title": "A Study of SPY072 in Rheumatic Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis", "Psoriatic Arthritis", "Axial Spondyloarthritis", "Rheumatic Diseases", "Rheumatic Joint Disease", "PsA (Psoriatic Arthritis)", "AxSpA", "Rheumatologic Disease" ], "interventions": [ { "name": "SPY002-072", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Spyre Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 285, "start_date": "2025-08-21", "completion_date": "2028-03-31", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 18, "location_summary": "Avondale, Arizona • Tucson, Arizona • Chula Vista, California + 14 more", "locations": [ { "city": "Avondale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Covina", "state": "California" }, { "city": "Tujunga", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07148414" }, { "nct_id": "NCT01118728", "title": "Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "Sarilumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 223, "start_date": "2010-06", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2017-06-21", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01118728" }, { "nct_id": "NCT00811499", "title": "A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "ARRY-371797, p38 inhibitor; oral", "type": "DRUG" }, { "name": "Placebo; oral", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2008-12-16", "completion_date": "2009-09-29", "has_results": false, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 7, "location_summary": "Los Angeles, California • Chicago, Illinois • Omaha, Nebraska + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00811499" }, { "nct_id": "NCT03473665", "title": "Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ankylosing Spondylitis", "Axial Spondyloarthritis" ], "interventions": [ { "name": "Indomethacin", "type": "DRUG" }, { "name": "Diclofenac", "type": "DRUG" }, { "name": "Meloxicam", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2018-03-01", "completion_date": "2019-08-02", "has_results": true, "last_update_posted_date": "2020-09-22", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03473665" }, { "nct_id": "NCT04163016", "title": "A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis", "Psoriatic Arthritis", "Crohn's Disease", "Axial Spondyloarthritis", "Plaque Psoriasis" ], "interventions": [ { "name": "Pharmacokinetics of certolizumab pegol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 22, "start_date": "2020-06-19", "completion_date": "2023-05-23", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 3, "location_summary": "Minneapolis, Minnesota • Durham, North Carolina • Oklahoma City, Oklahoma", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT04163016" }, { "nct_id": "NCT00056849", "title": "Genetic Determinants of Ankylosing Spondylitis Severity", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 134, "start_date": "2003-03-24", "completion_date": "2020-01-03", "has_results": false, "last_update_posted_date": "2020-01-07", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00056849" }, { "nct_id": "NCT01649375", "title": "16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anklyosing Spondylitis" ], "interventions": [ { "name": "Secukinumab (75 mg)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Secukinumab (150 mg)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 219, "start_date": "2012-10-18", "completion_date": "2018-09-18", "has_results": true, "last_update_posted_date": "2019-10-30", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 10, "location_summary": "Mesa, Arizona • Upland, California • Edina, Minnesota + 6 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Upland", "state": "California" }, { "city": "Edina", "state": "Minnesota" }, { "city": "Tupelo", "state": "Mississippi" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT01649375" }, { "nct_id": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Acute COVID-19 Syndrome", "ME/CFS", "Rheumatic Arthritis", "Juvenile Rheumatoid Arthritis (JRA)", "Psoriatic Arthritis (PsA)", "Ankylosing Spondylitis (AS)", "Autoimmune Encephalitis", "Celiac Disease", "Celiac Disease in Children", "Chronic Lyme Disease", "Post-treatment Lyme Disease Syndrome", "Crohn's Disease", "Dysautonomia", "Anorexia Nervosa", "Bulimia Nervosa", "ARFID", "Avoidant / Restrictive Food Intake Disorder", "Ehlers Danlos Syndrome", "Endometriosis", "Fibromyalgia (FM)", "Long COVID", "Lupus", "Migraines", "Mast Cell Activation Syndrome", "Multiple Sclerosis", "Myalgic Encephalomyelitis (ME)", "Myasthenia Gravis, Generalized", "Myasthenia Gravis in Children", "Narcolepsy", "Obsessive Compulsive Disorder (OCD)", "PANDAS", "Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)", "POTS - Postural Orthostatic Tachycardia Syndrome", "General Anxiety Disorder, Social Anxiety Disorder", "PTSD - Post Traumatic Stress Disorder", "Psoriasis", "Traumatic Brain Injury", "Tourette's Syndrome", "Inflammatory Bowel Disease (IBD)", "Autoimmune Diseases", "Neurological Diseases or Conditions", "Psychiatric Disorder", "Sjogren's Syndrome", "Ulcerative Colitis and Crohn's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Brain Inflammation Collaborative", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 10000, "start_date": "2023-07-05", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 1, "location_summary": "Delafield, Wisconsin", "locations": [ { "city": "Delafield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04806620" }, { "nct_id": "NCT06555562", "title": "Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psoriatic Arthritis", "Rheumatoid Arthritis", "Ankylosing Spondylitis" ], "interventions": [ { "name": "Ultrasound Stimulation", "type": "DEVICE" }, { "name": "Non-active ultrasound stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Surf Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "22 Years to 75 Years" }, "enrollment_count": 16, "start_date": "2025-10-01", "completion_date": "2026-01-05", "has_results": false, "last_update_posted_date": "2026-01-07", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 2, "location_summary": "Austin, Texas • Houston, Texas", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06555562" }, { "nct_id": "NCT04795141", "title": "ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "ABY-035", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Inmagene LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2021-08-24", "completion_date": "2022-08-30", "has_results": false, "last_update_posted_date": "2023-07-12", "last_synced_at": "2026-05-22T04:15:13.638Z", "location_count": 15, "location_summary": "Glendale, Arizona • Canoga Park, California • Huntington Beach, California + 12 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04795141" } ] }